← Eichor
Study identifier: NCT04190589 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer

Condition: Colorectal Cancer  ·  Sponsor: Vejle Hospital

PhaseNA
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A single-center prospective study to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) can be attained. Patients with colonic cancer near the right flexure or the oral part of the transverse colon will be compared excluding the most technically demanding and frail patients in both groups. A total of 40 patients undergoing e-RARC in a prospective series will be included and compared with 44 consecutive patients previously treated with e-ORC.

This description comes directly from the study's public registry record.

Talk to the study team

Hans B Rahr, MD DMSc  ·  +4520574529  ·  hans.rahr@rsyd.dk

Lars Bundgaard, MD  ·  +4579405618  ·  lars.bundgaard@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Vejle Hospital, Department of SurgeryVejle, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04190589